The company operates a healthcare facility in Kolkata providing outpatient clinics, diagnostic laboratories, indoor nursing home services, and retail pharmacies.
The company operates in a highly fragmented and increasingly competitive regional market with low barriers to entry. While it maintains decent net margins, the lack of revenue growth and declining EPS suggest no durable pricing power or scale advantage.
Management maintains a debt-free balance sheet and consistently pays dividends, but has failed to generate organic growth. Reinvestment is limited to routine equipment upgrades rather than strategic expansion.
The business entered a slow death spiral as its core healthcare operations remained stagnant while regional competition intensified. Management's refusal to aggressively reinvest or expand beyond routine maintenance allowed more nimble competitors to capture market share, turning the company into a glorified investment trust. As 'Other Income' became the primary driver of the bottom line, the market eventually re-rated the stock from a healthcare provider to a low-yield holding company, leading to a permanent collapse in the earnings multiple and a total loss of investor interest.
RichFakir rates N G Industries Ltd's business quality as poor — 36/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, N G Industries Ltd is trading about 29% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on N G Industries Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of N G Industries Ltd's fair value is about ₹79 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →